OXZ_PopPK
Indication: Partial-onset seizures in adults and children ≥ 2 years
Interactive simulator for oxcarbazepine (OXZ) and its active metabolite MHD population pharmacokinetics in pediatric patients including children with obesity. Based on allometric PKWT-scaled 1-CMT parent-metabolite model from Samant et al. 2025.
Drug Overview
Clinical Context
- Molecular Target
- Antiepileptic / Sodium channel blocker
- Drug Class
- Antiepileptic Drug (AED)
- Therapeutic Area
- Neurology / Epilepsy
- Indication
- Partial-onset seizures in adults and children ≥ 2 years
- Route of Administration
- Oral
Model Information
- Model Type
- 1-CMT Joint Parent-Metabolite PopPK (PKWT-scaled allometric)
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for OXZ_PopPK allows you to explore concentration-time profiles under different dosing scenarios. The underlying 1-CMT Joint Parent-Metabolite PopPK (PKWT-scaled allometric) model characterizes the pharmacokinetics of this antiepileptic drug (aed) following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the OXZ_PopPK PK simulator?
This is a free, interactive pharmacokinetic simulator for OXZ_PopPK used in Partial-onset seizures in adults and children ≥ 2 years. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does OXZ_PopPK belong to?
OXZ_PopPK is classified as a Antiepileptic Drug (AED) that targets Antiepileptic / Sodium channel blocker. It is used in the Neurology / Epilepsy therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of OXZ_PopPK. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 1-CMT Joint Parent-Metabolite PopPK (PKWT-scaled allometric) model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the OXZ_PopPK simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community